Wells Fargo & Company Ab Cellera Biologics Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 12,880 shares of ABCL stock, worth $37,609. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,880

Previous 15,680 17.86%

Holding current value

$37,609

Previous $46,000 28.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.39 - $3.49 $6,692 - $9,772	-2,800 Reduced 17.86%	12,880 $33,000
Q2 2024 Aug 13, 2024	SELL	$2.73 - $4.73 $33,950 - $58,822	-12,436 Reduced 44.23%	15,680 $46,000
Q1 2024 May 10, 2024	SELL	$4.29 - $5.97 $9,438 - $13,134	-2,200 Reduced 7.26%	28,116 $127,000
Q4 2023 Feb 09, 2024	SELL	$3.91 - $5.93 $25,512 - $38,693	-6,525 Reduced 17.71%	30,316 $173,000
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $345,639 - $597,355	-75,139 Reduced 67.1%	36,841 $169,000
Q2 2023 Aug 15, 2023	SELL	$5.66 - $7.59 $176,342 - $236,474	-31,156 Reduced 21.77%	111,980 $723,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $429,871 - $657,451	58,806 Added 69.73%	143,136 $1.08 Million
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $70,540 - $108,043	7,441 Added 9.68%	84,330 $854,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $34,941 - $51,956	3,798 Added 5.2%	76,889 $760,000
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $57,428 - $106,926	10,040 Added 15.92%	73,091 $778,000
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $217,324 - $411,926	-29,132 Reduced 31.6%	63,051 $615,000
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $704,161 - $961,107	-54,208 Reduced 37.03%	92,183 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $1.42 Million - $2.04 Million	95,669 Added 188.61%	146,391 $2.93 Million
Q2 2021 Aug 16, 2021	SELL	$20.19 - $34.17 $503,740 - $852,541	-24,950 Reduced 32.97%	50,722 $1.12 Million
Q1 2021 May 13, 2021	BUY	$23.29 - $53.2 $1.76 Million - $4.02 Million	75,472 Added 37736.0%	75,672 $2.57 Million
Q4 2020 Feb 09, 2021	BUY	$39.0 - $58.9 $7,800 - $11,780	200 New	200 $8,000

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ab Cellera Biologics Inc. Transaction History